Appointments and Affiliations
Ph.D., Johns Hopkins University, Biostatistics, 1999.
B.S., Peking University, Computational Mathematics, 1992.
Dr. Ying Qing Chen is a Full Member at the Fred Hutchinson Cancer Research Center and Affiliate Professor of Biostatistics at the University of Washington. Dr. Chen obtained his doctoral degree in Biostatistics from the Department of Biostatistics at Johns Hopkins University. He was the Sweesy-Womack Assistant Professor of Biostatistics at UC Berkeley and Associate Professor of Biostatistics at the University of Florida prior to joining the Hutchinson Center faculty in 2004. His expertise is in the development of statistical methods for analysis of survival and longitudinal data from clinical trials and epidemiological studies. Since joining the Center, Dr. Chen has been statistician on several Phase III trials: including HIVNET 024, HPTN 046, and HPTN 052.
2004-2011: Associate Member, Fred Hutchinson Cancer Research Center, Program in Biostatistics and Biomathematics, Public Health Sciences Division (PHS) and Vaccine and Infectious Disease Division (VIDD)
2003-2004: Associate Professor, University of Florida, Division of Biostatistics, Department of Statistics
1999-2004: Assistant Professor, University of California, Division of Biostatistics, School of Public Health
2004-Present: Affiliate Associate, Full Professor, Department of Statistics, University of Washington
American Statistical Association
International Biometric Society
International Chinese Statistical Association
Society for Clinical Trials
International AIDS Society
Honors and Awards
2003-2004: Stanley Schor Visiting Scholar, Merck Research Laboratories, Rahway, NJ
2001-2004: Sweesy-Womack Endowed Chair, University of California, Berkeley, CA
2001-2002: Hellman Family Faculty Fund, University of California, Berkeley, CA
1999-2000: Student Award and Travel Fellowship, ICSA, Washington, DC
1999-2000: The Thomas Charlmers Award, SCT, Anaheim, CA
1999-2000: Margaret Merrell Award, Johns Hopkins University, Baltimore, MD
1998-1999: Young Investigators Travel Grant to IBS, Cape Town, South Africa
- NIH/NCI: Statistical Methods for Medical Studies; Investigator (PI: Ross Prentice), 2006-2016.
- NIH/Pending: Statistical Methods for Dissecting Time-Varying GxE Interactions; Investigator (PI: Lue Ping Zhao), 2012-2015
- NIH/NIAID: Statistical Methods in HIV/AIDS Research, Principal Investigator, 2010-2013
- NIH/NIAID: Leadership for HIV/AIDS Clinical Trials Network, Investigator (PI: Deborah Donnell), 2004-2013.
- NIH/NIAID: Statistical Methods for HIV/AIDS Research, Sub-Award Principal Investigator (PI: Mei-Cheng Wang), 2008-2012.
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.. The New England journal of medicine. 375(9):830-9.. 2016.
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.. Journal of acquired immune deficiency syndromes (1999). 72(3):304-309.. 2016.
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.. Journal of acquired immune deficiency syndromes (1999). 73(5):606-608.. 2016.
Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.. Journal of acquired immune deficiency syndromes (1999).. 2016.
Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial.. Journal of acquired immune deficiency syndromes (1999).. 2016.
On estimation of covariate-specific residual time quantiles under the proportional hazards model.. Lifetime data analysis.. 2015.
Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.. Journal of acquired immune deficiency syndromes (1999). 69(2):234-40.. 2015.
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.. The New England journal of medicine. 369(18):1715-25.. 2013.
Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions.. Journal of acquired immune deficiency syndromes (1999). 63 Suppl 2:S130-4.. 2013.
Proportional mean residual life model for right-censored length-biased data.. Biometrika. 99(4):995-1000.. 2012.
Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial.. The Journal of infectious diseases. 204 (12):1918-1926.. 2011.
Prevention of HIV-1 infection with early antiretroviral therapy.. The New England journal of medicine. 365(6):493-505.. 2011.
Estimating a Scale-change Effect for Time-varying Phenotypes in Genome-wide Association Studies . Journal of Applied Statistical Science. 18(4):31-46.. 2011.
Semiparametric regression in size-biased sampling.. Biometrics. 66(1):149-58.. 2010.
Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa.. Journal of acquired immune deficiency syndromes (1999). 54(3):311-6.. 2010.
An Imputation Method for Interval Censored Time-to-Event with Auxiliary Information: Analysis of the Timing of Mother-to-Child Transmission of HIV. Statistical Communications in Infectious Diseases. 2(1). 2010.
Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.. Pediatrics. 124(1):e137-44.. 2009.
Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa.. The Pediatric infectious disease journal. 27(3):251-6.. 2008.